JPS635078B2 - - Google Patents
Info
- Publication number
- JPS635078B2 JPS635078B2 JP61278118A JP27811886A JPS635078B2 JP S635078 B2 JPS635078 B2 JP S635078B2 JP 61278118 A JP61278118 A JP 61278118A JP 27811886 A JP27811886 A JP 27811886A JP S635078 B2 JPS635078 B2 JP S635078B2
- Authority
- JP
- Japan
- Prior art keywords
- ncs
- substance
- fraction
- neocarzinostatin
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QZGIWPZCWHMVQL-DZANSKTCSA-N zinostatin Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3(C3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-DZANSKTCSA-N 0.000 claims description 15
- QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 claims description 9
- 229950009268 zinostatin Drugs 0.000 claims description 9
- 101710204212 Neocarzinostatin Proteins 0.000 claims description 8
- 239000003972 antineoplastic antibiotic Substances 0.000 claims description 5
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000003495 polar organic solvent Substances 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000126 substance Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 241000187747 Streptomyces Species 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 108010045882 preneocarzinostatin Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- OIPPWFOQEKKFEE-UHFFFAOYSA-N orcinol Chemical compound CC1=CC(O)=CC(O)=C1 OIPPWFOQEKKFEE-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000009916 Yoshida Sarcoma Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 238000006149 azo coupling reaction Methods 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61278118A JPS62244385A (ja) | 1986-11-21 | 1986-11-21 | 新制癌性抗生物質ｎｃｓ−ｃの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61278118A JPS62244385A (ja) | 1986-11-21 | 1986-11-21 | 新制癌性抗生物質ｎｃｓ−ｃの製造法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59262494A Division JPS6163290A (ja) | 1984-12-12 | 1984-12-12 | 新制癌性抗生物質ｎｃｓ−ｃの製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62244385A JPS62244385A (ja) | 1987-10-24 |
| JPS635078B2 true JPS635078B2 (enrdf_load_stackoverflow) | 1988-02-02 |
Family
ID=17592866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61278118A Granted JPS62244385A (ja) | 1986-11-21 | 1986-11-21 | 新制癌性抗生物質ｎｃｓ−ｃの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62244385A (enrdf_load_stackoverflow) |
-
1986
- 1986-11-21 JP JP61278118A patent/JPS62244385A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62244385A (ja) | 1987-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SHIOMI et al. | New antibiotic produced by Micromonospora globosa | |
| KR0163202B1 (ko) | 항종양성 물질 be-13793c | |
| KR100659680B1 (ko) | 항생 물질 카프라자마이신류 및 그 제조법 | |
| Cornish et al. | Preparation and DNA-binding properties of substituted triostin antibiotics | |
| JPS635078B2 (enrdf_load_stackoverflow) | ||
| JPH0832699B2 (ja) | キセノクマシン | |
| JPS6127039B2 (enrdf_load_stackoverflow) | ||
| CN103483354A (zh) | 一类色酮类化合物及其制备方法和在制备抗肿瘤与酶抑制剂药物中的应用 | |
| KR0177585B1 (ko) | 항종양성 물질 b e-13793c-생성 균주 | |
| KR960016206B1 (ko) | Bu-3862t 항종양 항생제 | |
| JPS6219156B2 (enrdf_load_stackoverflow) | ||
| JPS6212227B2 (enrdf_load_stackoverflow) | ||
| JPS62294676A (ja) | パチュロリドおよびその製造法 | |
| JPS6361959B2 (enrdf_load_stackoverflow) | ||
| US4835287A (en) | Antibiotic substance | |
| EP0185979A1 (en) | A novel substance having anti-tumor activity, a microbiological process for the preparation thereof and its use as a medicament | |
| KR0130473B1 (ko) | 새로운 항생물질, 베나노마이신 a와 b 및 덱실오실베나노마이신 b와 이들의 제조 방법과 용도 | |
| US5756320A (en) | Bioactive substances K93-0711 I-1 and I-2 and process for production thereof | |
| JPH0341069A (ja) | 抗腫瘍性物質ｂｅ―１３７９３類 | |
| US5093248A (en) | BU-3862T antitumor antibiotic | |
| CA1077421A (en) | Antibiotic sf-1540 from streptomyces | |
| JPS6030679B2 (ja) | 新制癌性抗生物質ｎｃｓ−ｃ | |
| CH624992A5 (enrdf_load_stackoverflow) | ||
| JPH0571234B2 (enrdf_load_stackoverflow) | ||
| JPH05222086A (ja) | 抗生物質アルデカルマイシンとその製造法、並びにその誘導体とその製造法 |